Real-world visual acuity outcomes between ranibizumab and aflibercept in treatment of neovascular AMD in a large US data set

PURPOSE: To examine 12-month real-world visual acuity outcomes and treatment patterns in neovascular age-related macular degeneration (nAMD) eyes, including those with pigment epithelial detachment (PED), receiving ranibizumab or aflibercept. PATIENTS AND METHODS: Electronic medical records were use...

Descripción completa

Detalles Bibliográficos
Autores principales: Lotery, A, Griner, R, Ferreira, A, Milnes, F, Dugel, P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733295/
https://www.ncbi.nlm.nih.gov/pubmed/28731052
http://dx.doi.org/10.1038/eye.2017.143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733295/
https://www.ncbi.nlm.nih.gov/pubmed/28731052
http://dx.doi.org/10.1038/eye.2017.143

Ejemplares similares